Stocks
ACADIA Pharmaceuticals Inc.ACAD
NASDAQHealthcareBiotechnology$20.61-3.10%
Focused on therapies for central nervous system disorders, this biopharmaceutical company develops and commercializes treatments for conditions with limited options, including Parkinson’s disease psychosis and Rett syndrome. Revenue is driven primarily by Nuplazid, with newer products such as Daybue...
Market Cap: $3.5B52W Range: $13.40 – $28.35
This page tracks all publicly disclosed congressional trades in ACADIA Pharmaceuticals Inc. (ACAD), a company in the Healthcare sector. 3 members of Congress have disclosed trades in this stock, including 1 purchase and 3 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
4
Unique Politicians
3
Buys
1
Sells
3
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-06-16 | Christopher L. Jacobs | sell | $1K – $15K |
| 2020-09-08 | Christopher L. Jacobs | sell | $1K – $15K |